Related Experiment Video
Updated: Mar 29, 2026
07:29
Rat Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy ALPPS Procedure
Published on: August 14, 2017
15.6K
Simultaneous Liver-Kidney Allocation Policy: A Proposal to Optimize Appropriate Utilization of Scarce Resources
R N Formica1, M Aeder2, G Boyle3
1Yale University School of Medicine, New Haven, CT.
Summary
The new Organ Procurement and Transplantation Network (OPTN) policy for simultaneous liver-kidney transplants addresses the lack of medical criteria. This aims to improve organ allocation and reduce wastage of kidneys from deceased donors.
Area of Science:
- Transplantation Medicine
- Organ Allocation Policy
- Nephrology
Background:
- The Mayo End-Stage Liver Disease score's inclusion in liver allocation increased simultaneous liver-kidney transplants.
- Predicting renal function recovery in liver transplant candidates remains a clinical challenge.
- Current simultaneous liver-kidney allocation lacks standardized medical eligibility criteria, conflicting with OPTN policy.
Purpose of the Study:
- To present the new Organ Procurement and Transplantation Network (OPTN) simultaneous liver-kidney allocation policy.
- To provide the evidence and rationale supporting the new policy.
- To address the critical need for standardized medical criteria in liver-kidney allocation.
Main Methods:
- Analysis of existing OPTN deceased donor liver allocation policies.
- Review of clinical data regarding renal insufficiency in liver transplant candidates.
- Examination of donor kidney utilization in simultaneous liver-kidney transplants.
Main Results:
- The new OPTN policy establishes medical criteria for simultaneous liver-kidney allocation.
- The policy aims to optimize the use of donor kidneys, particularly those from donors with a low Kidney Donor Profile Index.
- Implementation of the policy is expected to align with OPTN's Final Rule and improve organ distribution.
Conclusions:
- The new policy provides a framework for evidence-based simultaneous liver-kidney allocation.
- Standardized criteria are essential for equitable and efficient organ distribution.
- This policy aims to improve outcomes for patients needing both liver and kidney transplants while conserving valuable donor organs.
More Related Videos
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
256
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
256
01:28Kidney Transplant I: Introduction
691
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
691
01:26Kidney Transplant II: Surgical Procedure
779
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
779
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
335
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
335
01:16Hepatic Drug Excretion: Influencing Factors
743
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
743
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
296
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
296